Colchicine Dosing for Post-Operative Pericarditis

Key Principles

The European Society of Cardiology recommends weight-adjusted colchicine dosing: 0.5 mg once daily for patients <70 kg or 0.5 mg twice daily for patients ≥70 kg, continued for 3 months, for post-operative pericarditis with confirmed systemic inflammation 1
Colchicine is not recommended for postoperative effusions in the absence of systemic inflammation, as stated by the European Heart Journal 2, 3
The diagnosis of post-cardiac injury syndrome requires at least 2 of 5 criteria: fever, chest pain, pericardial/pleural rubs, pericardial effusion, or pleural effusion with elevated inflammatory markers, according to the European Heart Journal 3
Demonstration of inflammatory activity is essential before initiating treatment, as emphasized by the European Heart Journal 2, 3

The European Heart Journal suggests a weight-based dosing schedule: 0.5 mg once daily if <70 kg; 0.5 mg twice daily if ≥70 kg 4, 1
The treatment duration is 3 months, as recommended by the European Heart Journal 4, 1
Colchicine should be added to aspirin or ibuprofen, according to the European Heart Journal 4, 1
NSAIDs are generally not indicated for asymptomatic post-surgical effusions and may increase side effect risk, as stated by the European Heart Journal 2, 3

Meta-analysis of RCTs showed colchicine reduced post-pericardiotomy syndrome risk, with an odds ratio of 0.38, according to the European Heart Journal 2, 3
Perioperative colchicine use was effective but associated with increased gastrointestinal side effects compared to postoperative use, as reported by the European Heart Journal 2, 3
For established post-operative pericarditis, colchicine improves remission rates and reduces recurrence risk, according to the European Heart Journal 2, 3

The European Heart Journal recommends using inflammatory markers to guide treatment length and assess response 4, 1
Treatment should be continued until complete symptom resolution and inflammatory marker normalization, as suggested by the European Heart Journal 5
Monitor for recurrence, which occurs in <4% of post-pericardiotomy syndrome cases, according to the European Heart Journal 2, 3